Obstetrics

New research reveals that women with eclampsia show significantly higher rates of brain abnormalities, offering insight into unexplained neurologic symptoms during pregnancy.

Daily trimethoprim–sulfamethoxazole in pregnancy reduced preterm births, especially in women with HIV, but did not significantly affect birth weight.

Learn how to identify early symptoms of preeclampsia and improve outcomes with timely screening, diagnosis, and prevention strategies from Eran Bornstein, MD.

Comprehensive first trimester screening can identify over 90% of early preeclampsia cases, allowing timely intervention with low-dose aspirin to significantly reduce risks for both mother and baby.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals higher rates of severe maternal complications among Black and Hispanic patients with prior cesarean births, highlighting the need for equity-focused care strategies.

Learn how postpartum psychosis impacts maternal health, the role of family history, and key steps to identify and prevent this serious but treatable condition.

A universal aspirin initiative at a Bronx hospital increased prescribing rates from 30% to 99% and is now being evaluated for its impact on preeclampsia.

New research reveals a strong genetic connection in postpartum psychosis, emphasizing the need for early screening in high-risk women.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals worsening mental and physical health among female parents, highlighting growing disparities across race, income, and family structure.

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule.

A new study finds that a daily 150 mg dose of aspirin significantly improves thromboxane B2 inhibition compared to 75 mg in pregnant women at risk for preeclampsia.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study found that biologic treatment rates decline during pregnancy and only partially rebound postpartum, with trends varying by autoimmune condition.

A study found the greatest reduction in neonatal mortality occurs when antenatal corticosteroids are given 24 hours to 14 days before preterm delivery.

Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.

Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.

In this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.

A study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found women who experience intimate partner violence are more likely to have short interpregnancy intervals and mental health disorders.

A study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that fine particulate matter exposure during pregnancy is associated with increased odds of spontaneous preterm birth.

Despite widespread awareness of guidelines, many health care providers fall short in consistently screening and referring postpartum women for depression, putting maternal mental health at risk.

Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.

Laurence Shields, MD, shares details from his latest study on hemorrhage control devices for postpartum hemorrhage at the 2025 ACOG ACSM.

A new study presented at 2025 ACOG Annual Clinical and Scientific Meeting found disparities between RSV uptake in pregnant patients.